skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8850

Editorial: On the diversity of biological therapeutics ||Free Paper||

(2814) Views  (512) Full article downloads

Authors: Sanjay Awasthi

Published Date January 2007 Volume 2007:1(3) Pages 183 - 184
DOI: http://dx.doi.org/10.2147/BTT.S

Sanjay Awasthi

Professor of Biology and Associate Vice President for Clinical Research at University of North Texas Health Sciences Center; Medical Oncologist, Texas Oncology; Partner, US Oncology

Increasingly precise definition of the molecular nature of disturbances in cellular homeostasis that characterize different disease is leading to an astounding array of novel and effective therapeutics. These are appearing at a rate unrivaled in history. Certainly, not all of these are simply the product of new development. For instance, the idea of enzyme replacement therapy has long roots, but advances in recombinant protein production and delivery techniques have led to successful implementation of enzyme replacement therapy; dosing is being optimized in clinical studies, and it appears that greater benefit will be realized with earlier therapy.








Readers of this article also read:
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University

  • Journal Indexing

    See where all the Dove Press journals are indexed